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Background: Throughout industrialized countries, tobacco consumption is seen as the predominant driver of both
the trend and the extent of gender differences in life expectancy. However, several factors raise doubts to this
generalization. We hypothesize that the impact of smoking on the gender gap is context-specific and differs
between populations. Methods: We decompose the gender differences in life expectancy into fractions caused by
smoking and other non-biological factors for 53 industrialized countries and the period 1955–2009 to assess the
significance of smoking among the causes that can be influenced by direct or indirect interference. Results:
The trend of the gender gap can indeed be attributed to smoking in most populations of the western world.
However, with regard to the overall extent of male excess mortality, smoking is the main driver only in the
minority of the studied populations. While the impact of smoking to gender differences in life expectancy
declines in all populations, the contribution of other non-biological factors is in most cases higher at the end
than at the beginning of the observation period. Conclusions: Over-generalized statements suggesting that
smoking is the main driver of the gender gap in all populations can be misleading. The results of this study
demonstrate that—regardless of the prevailing effect of smoking—many populations have still remarkable
potentials to further narrow their gender gaps in life expectancy. Although measures to further reduce the
prevalence of tobacco consumption must be continued, more attention should be directed to the growing
importance of other non-biological factors.
. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .
Introduction
Throughout the developed world, women live several years longerthan men. Yet, the gender gap shows huge variations and
underwent significant changes during the 20th century.1 Gender dif-
ferences (GD) in life expectancy (LE) remained more or less
constant until the 1940s and started to increase thereafter. This
trend came to a halt in most western populations at the beginning
of the 1980s, when the gap started to decrease immediately or after a
stalling of some years. In Eastern Europe, the trend reversal set in
during the 1990s and only recently reached Japan, the sole laggard of
the western world. Nonetheless, GD in LE are still striking in all
developed populations. They currently range from around 4 years
in Iceland and Israel to more than 12 years in Russia.
As all industrialized societies continue to age and the shares of
older people grow, women’s higher longevity and its causes have
become an ever more important topic in public health and social
policy.2 Ever since the 1970s, researchers have identified cigarette
consumption as the most important reason for GD in mortality
(e.g. Refs. 3–5), usually in direct relation to the so-called ‘smoking
epidemic model’6—a perspective that prevails until today (e.g.
Ref. 7).
However, several aspects raise doubts about the general validity of
this viewpoint. It is well known that GD in LE are caused by a
complex combination of biological (genetic, hormonal) and non-
biological (behavioural, economic, social, environmental and
cultural) factors.8,9 Within this network of causes, tobacco con-
sumption is just one of many non-biological risk factors, which
has an impact only from the mid-adult ages onwards. Moreover,
populations differ in the smoking prevalence of women and men
as well as the time and speed they pass through the smoking
epidemic.10 Although it appears plausible that trends in cigarette
consumption have played a decisive role in the observed changes
in GD in LE since the middle of the 20th century, it seems rather
unlikely that smoking is also responsible for most of the overall male
excess in mortality in each population of the developed world.
Finally, a general assessment is impeded by the fact that available
studies not only differ with regard to the investigated populations,
age groups and calendar years, but also the methods used for quan-
tifying overall mortality and mortality attributable to smoking (e.g.
Refs. 4, 5, 9, 11–13). All in all, the contribution of smoking to the
extent and the trend in mortality differences between women and
men is not as clear as often stated.
We hypothesize that the impact of smoking on GD in LE is
highly context-specific and differs between populations. To test
this hypothesis, we estimate the impact of smoking on GD in
LE from the middle of the 20th century until today for a large
number of populations using the same data and identical well-
established methods. Moreover, we compare the impact of
smoking to the combined effect of all other non-biological
factors. This approach is important for public health policies
because it enables us to assess the significance of tobacco con-
sumption among the causes leading to GD in LE that can be
influenced by human action as well as direct or indirect
political interference.
Methods
We decompose GD in LE at birth into three components: biological
factors, smoking, and other non-biological factors. The analysis
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covers 53 populations from developed countries and 55 years of
observation from 1955 to 2009. GD in LE are derived from period
life tables using age- and gender-specific data on mortality and the
population at risk for ages 0, 1–4, 5–9, 10–14, . . . , 80–84, 85+ from
the Mortality Database of the World Health Organization.14 We
summarize the data for single calendar years into 5-year periods
and calculate the gender gap by subtracting the LE of men from
that of women. Truncated time series are completed by extrapola-
tion based on GD in LE derived from data of the 2010 revision of the
United Nations World Population Prospects.15 Among the popula-
tions included to this study, GD in LE range between 1.7 years in
TYFR Macedonia in 1955/59 and 17.6 years in Bosnia and
Herzegovina in 1990/94.
Biological factors—defined as those components of mortality
that are neither due to individual behaviours nor to social or
environmental influences—constitute the natural basis for higher
female LE.16,17 However, corresponding quantifications are rare
and we found only five such attempts which are based on very
different approaches.18–22 They all agree on the modest size of the
naturally caused GD in LE with only minor deviations in the
estimated extent (up to a maximum of 30% or 2 years of LE).
We follow the approach suggested by Luy19 and quantify the
pertinent part of the gender gap from data of his study on
female and male Catholic order members as a function of the
overall GD in LE (see Ref. 23 for more details). The correspond-
ing estimates range between 0.5 and 1.6 years and thus lie within
the range of the above mentioned quantifications of the impact of
biological factors.
Smoking-attributable mortality is estimated with the Peto–Lopez
method.24 The required data on the causes of death are taken from
the WHO Mortality Database.14 The contribution of smoking to GD
in LE is estimated with the demographic standard tool for age- and
cause-specific decomposition.25 Truncated time series are completed
with a log-square function in keeping with the smoking epidemic
model. Across the analysed populations the estimated impact of
smoking on GD in LE ranges between 0.02 years in Tajikistan in
1955/59 and 5.0 years in Russia in 1990/94.
Finally, the impact of other non-biological factors is derived from
the difference between the overall GD in LE and the sum of the
estimates for smoking and biological factors. The estimated contri-
bution of other non-biological factors to the gender gap ranges
from 0.3 years in the Netherlands in 1955/59 to 12.6 years in
Bosnia and Herzegovina in 1990/94. The numerical estimates for
each country and period can be found in Online Supplementary
material S1.
Results
The decomposition of GD in LE into the effects of smoking and
other non-biological factors leads to four possible basic patterns
during the observation period:
(A) Trend and the extent of GD in LE were predominantly driven
by smoking.
(B) Trend of GD in LE was predominantly driven by smoking,
whereas the extent was mainly driven by other non-biological
factors.
(C) Trend of GD in LE was predominantly driven by other non-
biological factors, whereas the extent was mainly driven by
smoking.
(D) Trend and the extent of GD in LE were predominantly driven
by other non-biological factors.
Our analysis reveals that all four combinations of the causes
underlying the trends and extents of GD in LE can be found in
the 53 studied populations. Figure 1 illustrates these four basic
patterns represented by the Netherlands, France, Sweden and
Bulgaria. The x-axes of the graphs show the estimated contribution
of smoking measured in years of LE, whereas the y-axes show the
estimated contribution of other non-biological factors. Each circle
represents the estimate for a specific 5-year period. The arrows
between the circles illustrate the trend over time. The estimates for
the earliest (1955/59) and latest (2005/09) periods are highlighted in
black and white, respectively. The dotted diagonal lines show the
total GD in LE (with values given at one end of these lines). The
solid diagonal line divides the estimates into those indicating a
higher impact of smoking as compared with other non-biological
factors (area below the diagonal line) and vice versa.
For instance, the black circle in the time series for the Netherlands
(figure 1a) shows that the GD in LE was 3.4 years in 1955/59 (see
position between the dotted lines for 3 and 4 years). Smoking caused
2.2 years of this difference (position of the black circle on the x-axis),
while the other non-biological factors contributed 0.3 years of LE
surplus for women. The estimated impact of biological factors is not
illustrated in this graph. It is, however, included as background in-
formation as it is the difference between the total GD in LE and the
estimates for the contributions of smoking and other non-biological
factors. Thus, in the case of the Netherlands, biological factors are
estimated to contribute 0.9 years of difference in LE between women
and men in 1955/59.
The time series for the Netherlands exemplifies the trend of
changing GD in LE, which rose from 3.4 years in 1955/59 to a
maximum of 6.9 years in 1980/84 and then continuously declined
Figure 1 Trends of the impacts of smoking and other non-biological factors on gender differences (GD) in life expectancy at birth, selected
countries, 1955/59-2005/09. (a) Trends in GD predominantly driven by smoking. (b) Trends in GD predominantly driven by other non-biological
factors
Source: Own calculations with data of WHO14 and UN Population Division.15
The impact of smoking on gender differences in life expectancy 707
Downloaded from https://academic.oup.com/eurpub/article-abstract/25/4/706/2399079
by Vienna University Library of Economics and Business Administration user
on 11 December 2017
to 4.3 years in 2005/09. The fact that all circles are located in the
bottom right triangle of the graph indicates that the impact of
smoking was higher than that of other non-biological factors
throughout the entire observation period. Moreover, as the
increase of the gender gap in LE until the early 1980s and the
subsequent decrease develop predominantly along the x-axis we
can conclude that the changes in the trend were, as well, primarily
caused by smoking and only to a minor extent by other non-
biological factors. However, from the 1980s onwards, the contribu-
tion of smoking decreased to a lower level in 2005/09 as compared
with the initial period (1955/59), whereas the contribution of other
non-biological factors increased slowly but steadily from 0.3 to 1.6
years.
Figure 1a shows the patterns for trends in the gender gap that are
predominantly driven by smoking. The Netherlands is an example
for populations in which smoking contributed also stronger to the
overall GD in LE (pattern A). France is an example for populations
in which the trend was also predominantly caused by smoking, while
the overall GD was mainly due to other non-biological factors
(pattern B).
Figure 1b shows the patterns for trends in the gender gap that are
predominantly driven by other non-biological factors. Bulgaria is
typical for populations in which the trend was mainly caused by
other non-biological factors, while smoking was largely responsible
for the overall GD (pattern C). Finally, Sweden is an example for
populations in which other non-biological factors were predomin-
antly responsible for both the trend and the extent of GD in LE
(pattern D).
The figures for all countries are contained in Online
Supplementary material S1 and demonstrate the very different
trends in the gender gap as well as the differences in the impacts
of smoking and other non-biological factors. Figure 2 illustrates this
heterogeneity by arranging the 53 populations according to the four
basic patterns of causes responsible for GD in LE. To summarize
the impact of smoking and other non-biological factors on the
trend of the gender gap, we use the range of their contributions
over the whole period. The impact of the two components on
the overall extent of GD in LE is measured by their average contri-
butions (the corresponding data and a graphical illustration can be
found in Online Supplementary material S2). All in all, we find
similar numbers of populations in which both the trend and the
extent of GD in LE were predominantly driven by smoking and
populations in which the opposite held true, i.e. where both the
trend and the extent were predominantly driven by other non-
biological factors (17 and 15 populations, respectively). In another
17 populations, the trend of the gender gap was driven predomin-
antly by smoking, while the extent was mainly due to other non-
biological factors. Finally, in four populations from Central and
Eastern Europe, the development of GD in LE was predominantly
driven by other non-biological factors, while smoking was respon-
sible for a larger part of the extent.
Discussion
The innovative approach presented in this article permits a direct
comparison of the roles played by smoking and other non-biological
factors in trends of GD in LE since the mid-20th century. For this
reason, the results of our study are not only interesting from the
demographic and epidemiologic viewpoints but are also highly
relevant for public health policies. Yet, it is important to note that
this study has a number of limitations. First of all, the decompos-
ition of GD in LE into the effects of biological factors, smoking and
other non-biological factors can only be approximate because it
neglects the manifold interactions between biological and non-
biological factors. For instance, smoking is raising mortality from
coronary heart disease against which female hormones provide some
protective effect.26 In addition, sex hormones as well as sex differ-
ences in central cholesterol, serotonin levels and reproductive
function are shaping gendered health behaviours including
tobacco consumption.27 According to our approach to estimate
the impact of biological factors, these interaction effects appear to
be included in the estimated smoking-attributable mortality, but to
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Figure 2 Countries by impact of smoking and other non-biological factors on overall gender differences in life expectancy at birth and on
the trend of the gender gap during the period 1955-2009
Note: The impacts of smoking and other non-biological factors on the trend of the gender gap are assessed by the range of the contri-
butions over the whole observation period and the impacts of smoking and other non-biological factors on the overall extent of the gender
gap are assessed by the average contributions; the corresponding data can be found in Online Supplementary material S2
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be excluded from the mortality due to other non-biological factors
(see Ref. 23 for more details).
The estimates of the impacts of smoking and biological fac-
tors are based on specific assumptions which include further
uncertainties. Nonetheless, comparisons of alternative approaches
for estimating smoking-attributable mortality show that the
inherent insecurities and obtained results do not differ signifi-
cantly.28–30 Also the impact of the applied estimation strategy for
biological factors is low as the estimates obtained with different
approaches yield very similar results. However, we assumed that
both estimation procedures—i.e. those for the impacts of smoking
and biological factors—can be applied to all studied populations.
Although this seems to be a valid assumption with regard to the
quantification of biological factors, it might not hold true for the
Peto–Lopez method for the assessment of the impact of smoking
(see also Ref. 11).
Another limitation concerns the numerical indicators used in
figure 2 to assign the populations to specific causation patterns of
GD in LE. The averages and ranges of smoking and other non-
biological factors reflect solely the conditions and trends within
the observed time span from 1955 to 2009. The boundaries of this
period do not correspond the beginning and the end of the overall
trends in GD in LE and their causes, and they might include even
different stages of the analysed trends. For instance, the range of
smoking observed in the Netherlands describes the decline in the
impact of tobacco consumption since 1980, but not the increase
which started well before 1955. Hence, it is imperative to note
that the differentiation between the four basic patterns serves exclu-
sively the purpose to summarize the heterogeneity of impacts and
trends of smoking and other non-biological factors in a simple and
illustrative manner. The populations characterized by one of these
patterns cannot be seen as a homogeneous group for which specific
conclusions about the nature of GD in LE can be derived. For
instance, the gender gaps prevailing in Italy and Scotland have
been identified to be characterized by pattern A, although the
trends developed very differently, with Scotland ending up close to
the point at which Italy started (see Online Supplementary material
S1). Likewise, populations with apparently similar trends are
assigned to different patterns because of our classification criteria,
such as Sweden and Norway.
With these limitations in mind, we can conclude that our
hypothesis about the role of smoking in the causation of GD in
LE is confirmed regarding to the extent of the gender gap. But we
have to reject it with regard to the trend during the observation
period. The latter can indeed be attributed to smoking in most
populations of the western world, including Western Europe,
North America, Japan, Australia and New Zealand. The only
exceptions are Sweden, Iceland, Ireland and Israel whose popula-
tions are characterized by a low prevalence of smoking.31
Populations in which the trend of the gender gap is predominantly
driven by other non-biological factors are those from Eastern
Europe, where alcohol-related and external causes of death in
mid-adult ages are known to lead to an extraordinarily high
mortality among men,32 and from Latin America and South
Korea, which are still in the earliest stages of the tobacco epidemic
with a low level of smoking-attributable mortality.33
With regard to the overall extent of the gender gap we found that
smoking is the main driver only in a minority of the studied popu-
lations. Interestingly, these are exclusively located in Europe. This is
mainly due to the fact that the contribution of non-biological factors
other than smoking was considerably lower in European populations
during the observation period. A second reason is that most
European populations are already in the late stages of the smoking
epidemic. Consequently, the analysed time span includes the years of
maximum GD in smoking-attributable mortality for these popula-
tions, what is not the case for several non-European countries, such
as Chile, Mexico and South Korea.
A deeper analysis of the country-specific trends reveals some
additional, interesting details. The contribution of smoking to the
gender gap declines in all studied populations, although the
beginning of the decline varies in accordance with the model of
the smoking epidemic. However, in most populations, the contri-
bution of other non-biological factors—including alcohol consump-
tion, nutrition habits, physical exercise, specific infectious diseases,
external mortality (accidents, poisoning, homicides) and health risks
related to occupation—is higher at the end than at the beginning of
the observation period with France being one of the few exceptions.
Nevertheless, the patterns vary widely. In some populations (e.g.
Norway, Portugal, Mexico and South Korea), the impact of non-
biological factors other than smoking first rose and then dropped. In
other countries (e.g. Luxembourg, Poland and the Republic of
Moldova), the opposite holds true (initially decreasing, then
rising) or the impact continuously increased (e.g. in the UK, the
Netherlands, Finland and many Central and Eastern European
countries). The successor states of the former Soviet Union follow
a rollercoaster pattern in accordance with the well-documented
trends in alcohol-related mortality.34–36 In yet another group of
populations (e.g. North America, Australia, Italy and Greece), the
impact of these factors remained almost unchanged throughout the
observation time.
An important question that exceeds the scope of this article is
whether and to what extent the differences between populations in
terms of impact of smoking and other non-biological factors reflect
the effectiveness of specific public health strategies (see Ref. 37 for an
overview of different measures to reduce smoking prevalence). Most
importantly, it has been shown that women and men not only
exhibit different patterns of tobacco use,6 but they also respond
differently to specific tobacco control policies what should be
analysed in more detail.38 As well, further research is needed to
better understand the role of specific non-biological factors other
than smoking that cause the different trends of the gender gap across
populations, albeit it is likely that their impact is as heterogeneous
and context-dependent as that of smoking. For instance, it has been
shown that in Eastern Europe GD in LE are strongly influenced by
alcohol-related mortality, whereas in North America they are caused
predominantly by mortality related to accidents and violence.39,40
The data presented in Online Supplementary material S1 can serve
as basis for addressing these research questions and translating them
into effective and gendered public health programmes to prevent
or reduce tobacco consumption and other non-biological risk
factors.
Summing up, this study highlights the enormous heterogeneity in
impacts of smoking and other non-biological causes on GD in LE.
Hence, over-generalized statements which suggest that smoking is
the main force behind the gender gap in all developed populations
can be misleading. Our study shows that the public health sector
rather needs population-specific estimates to introduce the most
appropriate measures in order to further reduce the inequalities in
LE between women and men in the most effective way. In this
context, it is important to note that the overall decrease of the
impact of smoking causes on the one hand a decrease of the
gender gap but on the other comes along with an increase or stall
of the impact of other non-biological factors. The simplistic view
that smoking drives the whole non-biological component of GD
in LE entails the risk that the increasing importance of specific
other factors is overlooked. Thus, our results demonstrate that—
regardless of the prevailing effect of smoking—many populations
have still remarkable potentials to further narrow their gender
gaps in LE.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 This study presents the most extensive analysis of the impact
of smoking on the gender gap in LE ever done.
 The role of smoking is by far less clear and homogeneous
than commonly stated.
 Although the impact of smoking declines in all studied
populations, the impact of the other non-biological factors
increases in most countries.
 Populations in which not only the trend but also the extent
of the gender gap can be attributed predominantly to
smoking can be found exclusively in Europe.
 Many populations have still remarkable potentials to further
narrow the gender gap in LE.
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